Verapamil for severe hyperkinetic movement disorders

Movement Disorders

Volumn 13, Issue 2, 1998, Pages 341-344

  Ovsiew, Fred ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

tardive dyskinesia ; verapamil; Calcium channel blockers; Hyperkinetic movement disorders

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; HUMAN; HYPERKINESIA; MALE; NEUROLOGIC EXAMINATION;

ADULT; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERKINESIS; MALE; NEUROLOGIC EXAMINATION; VERAPAMIL;

EID: 0032013640     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130224     Document Type: Article

References (23)

1. Abad V, Ovsievv F. Treatment of persistent myoclonic tardive dystonia with verapamil. Br J Psychiatry 1993;I62:55-4-556.
2. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-77.
3. Bonuccelli U, Ceravolo R, Maremmani C, Nuti A, Rossi G, Muratorio A. Clozapine in Huntington's chorea. Neurology 1994;44: 821-823.
4. Gates M, Lusk K, Wells BG. Are calcium-channel blockers effective in the treatment of tardive dyskinesia? Ann Phannacother 1993:27:191-196.
5. Bartko G, Horvath S, Zador G, Frecska E. Effects of adjunctive verapamil administration in chronic schizophrenic patients. Prog Neuropsychophannacol Biol Psychiatry 1991:15:343-349.
6. Suddath RL, Straw GM, Freed WJ, Bigelow LB, Kirch DG, Wyatt RJ. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. Plmrmacol Biochem Beliav 1991:39:743-745.
7. Biary N, Bahou Y, Sofi MA, Thomas W, Al Deeb SM. The effect of nimodipine on essential tremor. Neurology 1995;45:1523-1525.
8. Mena MA, Garcia de Yébenes MJ, Tabernero C, Casarejos MJ, Pardo B, Garcia de Yébenes J. Effects of calcium antagonists on the dopamine system. Clin Neiiropharmacol 1995;18:410-426.
9. Di Renzo G, Amoroso S, Taglialatela M, Annunziato L. Dual effect of verapamil on K+-evoked release of endogenous dopamine from arcuate nucleus-median eminence complex. Neurosci Lett 1984:50:269-272.
10. Etou K, Kuroki T, Tatebayashi Y, Tashiro N, Hirano M. Effects of calcium antagonists nifedipine and flunarizine on phencyclidineinduced changes in the regional dopaminergic metabolism of the rat brain. Biochem Pharmacol 1996:51:83-86.
11. Gaggi R, Cont R, Gianni AM. Comparison among the effects of nifedipine, nimodipine and nisoldipine on the brain biogenic amines of normal or haloperidol treated rats. Gen Pharmacol 1993; 24:1091-1096.
12. Bangalore R, Hawthorn M, Triggle DJ. Iminodipropionitrile -induced dyskinesia in mice: striatal calcium channel changes and sensitivity to calcium channel antagonists. J Neurochem 1991;57: 550-555.
13. Pucilowski O, Eichelman B. Diltiazem suppresses quinpiroleinduced oral stereotypies in haloperidol withdrawn rats. Prog Neuropsychophamacol Biol Ps)-chiatry 1991;15:717-722.
14. Garcia Ruiz' PJ, Mena MA, Penafiel N, De Yebenes JG. Cinnarizine-induced parkinsonism in primates. Clin Neuropharmacol 1992:15:152-154.
15. Garcfa-Ruiz PJ, Garcfa de Yébenes J, Jiménez-Jiménez FJ, Vâzquez A, Garcfa Urra D, Morales B. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neurophannacol 1992;15:19-26.
16. Brücke T, Wöber C, Podreka I, et al. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects: a SPECT study. J Cereb Blood Flow Metab 1995;15:513-518.
17. Fadda F, Cessa GL, Mosca E, Stefanini E. Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain. J Neural Trans 1989;75:195-200.
18. Dick RS, Barold S. Diltiazem-induced parkinsonism. Am J Med 1989;87:95-96.
19. Jacobs MB. Diltiazem and akathisia. Ann Intern Med 1983;99: 794-795.
20. De Medina A, Biasini O, Rivera A, Sampera A. Nifedipine and myoclonic dystonia [Letter]. Ann Intern Med 1986;104:125.
21. Jeret JS, Somasundaram M, Asaikar S. Diltiazem-induced myoclonus. NY State J Med 1992;92:447-U8.
22. Hicks CB, Abraham K. Verapamil and myoclonic dystonia [Letter]. Ann Intern Med 1985:103:154.
23. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986;1:193-208.